1. Home
  2. VCYT vs BATRA Comparison

VCYT vs BATRA Comparison

Compare VCYT & BATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Veracyte Inc.

VCYT

Veracyte Inc.

N/A

Current Price

$32.95

Market Cap

2.8B

Sector

Health Care

ML Signal

N/A

Logo Atlanta Braves Holdings Inc. Series A

BATRA

Atlanta Braves Holdings Inc. Series A

N/A

Current Price

$47.97

Market Cap

2.7B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
VCYT
BATRA
Founded
2006
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Broadcasting
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.7B
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
VCYT
BATRA
Price
$32.95
$47.97
Analyst Decision
Strong Buy
Buy
Analyst Count
8
2
Target Price
$45.13
$57.00
AVG Volume (30 Days)
802.9K
53.3K
Earning Date
05-25-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
164.52
N/A
EPS
0.82
N/A
Revenue
N/A
N/A
Revenue This Year
$13.33
$12.40
Revenue Next Year
$12.53
$8.54
P/E Ratio
$41.38
N/A
Revenue Growth
N/A
N/A
52 Week Low
$22.61
$38.67
52 Week High
$50.71
$50.45

Technical Indicators

Market Signals
Indicator
VCYT
BATRA
Relative Strength Index (RSI) 34.55 58.30
Support Level $32.51 $45.81
Resistance Level $32.79 $48.05
Average True Range (ATR) 1.45 1.38
MACD -0.16 -0.10
Stochastic Oscillator 0.42 46.91

Price Performance

Historical Comparison
VCYT
BATRA

About VCYT Veracyte Inc.

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.

About BATRA Atlanta Braves Holdings Inc. Series A

Atlanta Braves Holdings Inc is a holding company. It operates through its wholly-owned subsidiary, which is the owner and operator of the Atlanta Braves Major League Baseball Club and the mixed-use real estate development, The Battery Atlanta, and is the operator of the Atlanta Braves Major League Baseball Club's stadium, Truist Park. The company predominantly derives revenue related to the Braves baseball franchise and Truist Park from ticket sales, concessions, local broadcasting rights, advertising sponsorships, suites and premium seat fees, retail and licensing revenue, shared MLB revenue streams, including national broadcasting rights and licensing, and other sources. The company's reportable segments include: Baseball which generates key revenue, and Mixed-Use Development.

Share on Social Networks: